Close
Presentations (slides, Video) and Abstract are available to GBCC Sign-up members.
You can access after log-in.
GBCC
Previous Meetings
GBCC Information
GBCC Resources
Previous Meetings
Photo Album
Announcement
What’s NEW
Previous Meetings (GBCC 2016)
※Photographing or reproducing slides, videos of presentations, and abstracts is strictly prohibited without prior permission from the presenter and/or the GBCC.
*Uploaded presentation materials and recording videos of presentation are under the copyright transfer agreement.
Day 1, Apr 28 (Thu) Day 2, Apr 29 (Fri) Day 3, Apr 30 (Sat)
07:30-08:10
  • Breakfast Symposium 2
      
  • Venue:  
    Halla Hall
  • Prophylaxis of Febrile Neutropenia: Experiences with Adjuvant TAC
    Jihyoun Lee (Soonchunhyang Univ. Hospital Seoul, Korea)Video ViewAbstract
08:00-09:30
  • Practicing Breast Surgeons Session: 
    Ultimate Tips of VABB Device  
  • Venue:  
    Weolla Room
  • Comparison of the Pros & Cons of VABB Devices, Bexcore, Mammotome and Encore
    Soo Jin Kim (Chungdam Seoul Breast Clinic, Korea)Slide View
  • Prevention and Management of VABB Complication
    Dong Seok Lee (Bunhongbit Hospital, Korea)Slide View
  • Knowhow to Perform VABB for Technically Difficult Accessible Breast Masses Subareolar Mass. Breast Mass Nearby Skin. Larger than 5cm Size Breast Mass
    Jeong Kyeung Kim (Maria Breast Clinic, Korea)Slide View
  • VABB Can Be an Excellent Tool for Biopsy of Microcalcifications: Micropure Guided VABB, J Wire Guided VABB
    Kyung Ho Cha (Mamma Breast Clinic, Korea)
  • Management of Premalignant Lesions after VABB. ADH, ALH, LCIS, Flat Epithelial Atypia, Columnar Cell Change, Papillary Lesions, Phyllodes Tumor
    Tae Ik Eom (HiU Breast Clinic, Korea)Slide View
  • Legal Consulting for Running Breast Clinic: Medical Insurance Issues with Law Firm
    Junseok Lee (Sunwoo LLC, Korea)Slide View
08:30-09:30
  • Plenary Lecture 5
      
  • Venue:  
    Halla Hall
  • Two Decades at the NSABP - B27 to 57, and Unsolved Mysteries
    Soonmyung Paik (Yonsei Univ. College of Medicine, Korea)Slide ViewVideo ViewAbstract
09:40-10:50
  • Symposium 8: 
    Enhancing Endocrine Therapy for ER-positive Breast Cancer: Co-targeting Signaling Pathways  
  • Venue:  
    Halla Hall
  • Sensitization of Breast Cancer Cells to Chemotherapeutic Drugs by Metabolic Regulation
    In-Chul Park (Korea Institute of Radiological and Medical Sciences, Korea)Slide ViewVideo ViewAbstract
  • Cross-talk between Adiponectin and IGF-IR in Breast Cancer
    Young-Jin Suh (The Catholic Univ. of Korea, St. Vincent's Hospital, Korea)Slide ViewVideo ViewAbstract
  • Bidirectional Crosstalk between the ER and HER2 Signaling Pathways: From Bench to Bedside
    Joohyuk Sohn (Yonsei Cancer Center, Korea)Slide ViewVideo ViewAbstract
  • Education Session 2: 
    Immune-oncologic Approaches as Innovative Therapeutic Strategy for Refractory Breast Cancer  
  • Venue:  
    Lotus Hall
  • Value of Immune Infiltration to Predict Therapeutic Outcomes
    Hee Jin Lee (ASAN Medical Center, Univ. of Ulsan College of Medicine, Korea)Video ViewAbstract
  • Immune Targeting in Breast Cancer
    Leisha A Emens (Johns Hopkins Univ.-School of Medicine, U.S.A)Video ViewAbstract
  • Combination Immunotherapy Approaches: Chemotherapy, Radiation Therapy, and Dual Checkpoint Therapy
    David Page (Providence Portland Cancer Center, Earle A. Chiles Research Institute, U.S.A.)Slide ViewVideo ViewAbstract
  • Oral Presentation 2
      
  • Venue:  
    Weolla Room
  • INVESTIGATION OF CYTOTOXIC AND APOPTOTIC EFFECTS OF URTICA DIOICA AGGLUTININ ON MCF-7 AND L929 CELL LINES
    Tutku Ozarpaci (Fatih Univ., Turkey)Slide ViewAbstract
  • SCREENING BY ABBREVIATED BREAST MAGNETIC RESONANCE IMAGING (MRI) IN WOMEN WITH A HISTORY OF BREAST CANCER OPERATION
    Bo Hwa Choi (Konkuk Univ. Medical Center, Korea)Slide ViewAbstract
  • ANALYSIS OF INTERVAL BREAST CANCER WITH A SINGLE CENTER DATASET
    Jae Yang Lim (Dr. Lim’s Breast Clinic, Korea)Slide ViewAbstract
  • ESTIMATING THE COST OF WORK LOSS OF CANCER SURVIVORS IN JAPAN
    Hideko Yamauchi (St. Luke's International Hospital, Japan)Slide ViewAbstract
  • THE RISK FACTORS OF PREGNANCY-ASSOCIATED BREAST CANCER IN KOREAN WOMEN
    Yun Gyoung Kim (Korea Cancer Center Hospital, Korea)Slide ViewAbstract
  • EFFICACY OF DOCETAXEL , TRASTUZUMAB AND PERTUZUMAB COMBINATION REGIMEN FOR HER2-POSITIVE METASTATIC BREAST CANCER
    Tsutomu Takashima (Osaka City Univ. Graduate School of Medicine, Japan)Slide ViewAbstract
  • INFLUENCE OF BODY MASS INDEX AT DIAGNOSIS IN RELATION TO HORMONE RECEPTOR, MENOPAUSAL AND NODAL STATUS ON BREAST CANCER PROGNOSIS
    Il Yong Chung (ASAN Medical Center, Korea)Abstract
  • THE DISTRIBUTION OF PROBANDS AND BRCA CARRIERS FROM 4 ASIAN BREAST CANCER STUDIES (SINGAPORE, CHINA AND KOREA)
    Heewon Kim (Seoul National Univ. College of Medicine, Korea)Slide ViewAbstract
10:50-12:00
  • Symposium 9: 
    New Area for Anti-cancer Drug Development in Breast Cancer  
  • Venue:  
    Halla Hall
  • Combination Strategy in Cancer Immuno-oncology Drug Development
    Soohyeon Lee (Pfizer Korea, Korea)Slide ViewVideo ViewAbstract
  • The Tumor Microenvironment: A Driving Force for Breast Cancer Progression
    Hyeong-Gon Moon (Seoul National Univ. College of Medicine, Korea)Slide ViewVideo ViewAbstract
  • Targeting the Androgen Receptor in Breast Cancer
    Elgene Lim (Garvan Institute of Medical Research, Australia)Slide ViewVideo ViewAbstract
  • Education Session 3: 
    New Paradigm for Overcoming Endocrine Resistance  
  • Venue:  
    Lotus Hall
  • New Paradigm for Overcoming Endocrine Resistance - Targeting CDK 4/6
    Jee Hyun Kim (Seoul National Univ. Bundang Hospital, Korea)Slide ViewVideo ViewAbstract
  • PI3K/mTORor Pathway
    Woochul Noh (Korea Cancer Center Hospital, Korea)Slide ViewVideo ViewAbstract
  • ESR1 Mutations-A Mechanism for Acquired Endocrine Resistance in Breast Cancer
    Kyong Hwa Park (Korea Univ. Anam Hospital, Korea)Slide ViewVideo ViewAbstract
  • Oral Presentation 3
      
  • Venue:  
    Weolla Room
  • SYNTHESIZATION, CHARACTERIZATION OF FOLIC ACID AND QUERCETIN FUNCTIONALIZED MAGNETIC NANOPARTICLES RESEARCH ON BREAST CANCER CELL LINE FOR HYPERTHERMIA AND TARGETED DRUG DELIVERY APPLICATIONS
    Zeynep Ulker Akal (Fatih Univ., Turkey)Slide ViewAbstract
  • BREAST CANCER RISK ASSOCIATIONS WITH DIGITAL MAMMOGRAPHIC DENSITY BY MAMMOGRAPHY DENSITY THRESHOLDS AND MAMMOGRAPHY SYSTEM
    Kevin Nguyen (The Univ. of Melbourne, Australia)Slide ViewAbstract
  • TARGETING A NOVEL CHEMORESISTANCE GENE, ZBTB2, TO OVERCOME CISPLATIN-RESISTANCE IN TRIPLE-NEGATIVE BREAST CANCER
    Vivian Shin (The Univ. of Hong Kong, Hong Kong)Slide ViewAbstract
  • THE ROLE OF PREOPERATIVE BREAST MAGNETIC RESONANCE (MR) IMAGING FOR SURGICAL DECISION IN PATIENTS WITH TRIPLE-NEGATIVE BREAST CANCER
    Jeeyeon Lee (Kyungpook National Univ. Hospital, Korea)Slide ViewAbstract
  • CHANGES OF ABDOMINAL FAT DISTRIBUTION AFTER ENDOCRINE THERAPY IN BREAST CANCER PATIENTS
    Jong Oh Lee (Hanyang Univ. College of Medicine, Korea)Slide ViewAbstract
  • DEVELOPMENT OF SECOND PRIMARY CANCERS IN KOREAN BREAST CANCER SURVIVORS
    Hong Kyu Jung (Soonchunhyang Univ. Hospital Seoul, Korea)Slide ViewAbstract
  • THE PRECISE QUANTIFICATION OF PROGESTERONE RECEPTOR COULD BE AN ALTERNATIVE TO THE RECURRENT SCORE IN HORMONE RECEPTOR-POSITIVE EARLY BREAST CANCER
    Moo Hyun Lee (National Cancer Center, Korea)Slide ViewAbstract
  • SIX-YEAR FOLLOW UP OF BREAST-CONSERVING SURGERY USING SUPINE MAGNETIC RESONANCE IMAGING IN BREAST CANCER PATIENTS RECEIVING PRIMARY SYSTEMIC THERAPY
    Takafumi Sangai (Chiba Univ., Japan)Slide ViewAbstract


Back to Previous Meetings+



Global Breast Cancer Conference Secretariat

Partner I INTERCOM Convention Services, Inc. (Core PCO)

TOP